🔎 Trials Near Me

ホーム › 多発性骨髄腫 › ノースカロライナ › Winston-Salem

Winston-Salem、NCにおける多発性骨髄腫の臨床試験

Winston-Salemとその周辺地域（約30マイル以内）の拠点で、多発性骨髄腫に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト（英語）

ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

被験者募集中第3相
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
18歳以上 · 全性別 · 2026/09/29更新 · NCT07391657

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

被験者募集中第2相
  • Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center, Winston-Salem
18歳〜80歳 · 全性別 · 2026/09/25更新 · NCT07149857

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

被験者募集中第2相
  • Wake Forest University, School of Medicine Dept. of Internal Medicine, Division of Hematology Oncology, Winston-Salem
60歳以上 · 全性別 · 2026/09/25更新 · NCT06052826

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

被験者募集中第3相
  • Novant Health Forsyth Medical Center, Winston-Salem
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
18歳以上 · 全性別 · 2026/09/25更新 · NCT05552222

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

被験者募集中第1/2相
  • Wake Forest Baptist Health /ID# 271294, Winston-Salem
18歳以上 · 全性別 · 2026/09/14更新 · NCT06953960

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

被験者募集中第3相
  • Forsythe Memorial Hospital Inc., dba Novant Health Oncology Specialists, Winston-Salem
18歳以上 · 全性別 · 2026/09/11更新 · NCT07555938

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

被験者募集中第3相
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
18歳以上 · 全性別 · 2026/08/14更新 · NCT07764978

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

被験者募集中第1/2相
  • Atrium Health Wake Forest Baptist Medical Center /ID# 274847, Winston-Salem
18歳以上 · 全性別 · 2026/07/21更新 · NCT06892522

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

被験者募集中第1相
  • Atrium Health Wake Forest Baptist Medical Center /ID# 251165, Winston-Salem
18歳以上 · 全性別 · 2026/07/13更新 · NCT05650632

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

被験者募集中第1相
  • Wake Forest University Health Sciences, Winston-Salem
18歳以上 · 全性別 · 2026/07/08更新 · NCT05137054

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

被験者募集中第3相
  • GSK Investigational Site, Winston-Salem
18歳以上 · 全性別 · 2026/04/22更新 · NCT06679101

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

被験者募集中観察研究
  • Wake Forest Baptist Health, Winston-Salem
18歳〜120歳 · 全性別 · 2026/04/13更新 · NCT01890486

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

被験者募集中第1/2相
  • Atrium Wake Forest Baptist Medical Center, Winston-Salem
12歳以上 · 全性別 · 2026/03/24更新 · NCT04988555

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

被験者募集中第1/2相
  • Atrium Health Wake Forest Baptist, Winston-Salem
18歳以上 · 全性別 · 2025/06/03更新 · NCT06119685

他の都市における多発性骨髄腫の試験

Winston-Salemにおける他の研究

ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。